The first injection in port A contained the substrate for each individual respiratory chain complex (I: 5 mM pyruvate + 2.5 mM malate, II: 10 mM succinate + 1 M rotenone, III: 0.5 mM duroquinol, IV: 0.5 mM TMPD + 2 mM ascorbic acid) along with 1 mM ADP and 10 nM recombinant perfringolysin O (Agilent Technologies)
The product is not intended to diagnose, treat, cure, or prevent any disease and should only be handled by qualified professionals operating within controlled scientific environments
Clin Pharmacol Ther 31:151156 Miners JO, Penhall R, Robson RA, Birkett DJ (1988) Comparison of paracetamol metabolism in young adult and elderly males
[DOI] [PubMed] [Google Scholar] 107.Vanga SK, Raghavan V
All pathological changes tend to regress when euthyroidism is achieved
Paris, I., Muoz, P., Huenchuguala, S., Couve, E., Sanders, L